NCT06422429

Brief Summary

The goal of this clinical trial is to investigate the effects of personalized innovative fritters on the nutritional health of overweight and obese individuals aged 40 to 70 years. The main questions it aims to answer are:

  • How does consuming personalized innovative fritters affect the nutritional health of overweight and obese individuals?
  • What is the mechanism underlying the impact of personalized innovative oil bars on nutritional health? Participants will be randomly assigned to one of two groups: a trial group consuming personalized innovative fritters and a control group consuming traditional fritters with equal energy content. Over the course of 6 months, participants will undergo two phases of intervention separated by a two-month washout period. During the intervention, participants will be assessed comprehensively for sensory ratings and nutritional health status through biological indicators, physical examinations, and other relevant measures. Researchers will compare the trial group to the control group to determine if personalized innovative fritters lead to improvements in nutritional health compared to traditional fritters.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started Mar 2025

Shorter than P25 for phase_2

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 17, 2024

Completed
4 months until next milestone

First Posted

Study publicly available on registry

May 21, 2024

Completed
9 months until next milestone

Study Start

First participant enrolled

March 1, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

May 21, 2024

Status Verified

January 1, 2024

Enrollment Period

6 months

First QC Date

January 17, 2024

Last Update Submit

May 17, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in HbA1c

    The investigators will measure HbA1c in blood samples before and after treatment.

    6 months

  • Change in blood glucose from baseline

    The investigators will measure fasting plasma glucose levels in blood samples before and after treatment.

    6 months

Secondary Outcomes (1)

  • Change in blood lipids from baseline

    6 months

Study Arms (2)

Control group

PLACEBO COMPARATOR

traditional Youtiao

Drug: Traditional deep-fried Youtiao

Intervention group

EXPERIMENTAL

Personalised and innovative Youtiao

Drug: PI Youtiao

Interventions

45g 4 times a week for 4 months

Control group

45g 4 times a week for 4 months

Intervention group

Eligibility Criteria

Age40 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age between 40-70 years old (women need to be menopausal);
  • BMI\>24 kg/m2;
  • Consumption of fritters more than once a week.

You may not qualify if:

  • history of diabetes mellitus, cardiovascular disease, dyslipidaemia, renal disease, -
  • liver disease or cancer;
  • surgical treatment within 3 months;
  • allergy/intolerance to the study food or any of its ingredients;
  • breastfeeding or pregnancy;
  • \>10% weight loss in the past 6 months;
  • smoking or alcohol abuse;
  • participation in another clinical study within the past 6 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Nutrition Disorders

Condition Hierarchy (Ancestors)

Nutritional and Metabolic Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
professor

Study Record Dates

First Submitted

January 17, 2024

First Posted

May 21, 2024

Study Start

March 1, 2025

Primary Completion

September 1, 2025

Study Completion

December 1, 2025

Last Updated

May 21, 2024

Record last verified: 2024-01